BioArctic
324.20 SEK
+2.92 %
Less than 1K followers
BIOA B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+2.92 %
-1.46 %
+4.31 %
+9.97 %
+36.10 %
+52.64 %
+18.32 %
+228.47 %
+1,017.93 %
BioArctic is a biopharmaceutical company focused on developing new treatments that address the causes of neurodegenerative diseases. Examples of diseases include Alzheimer's and Parkinson's. A large part of the research is carried out in collaboration with researchers at universities and hospitals. BioArctic was founded in 2003 and is headquartered in Stockholm.
Read moreMarket cap
28.74B SEK
Turnover
68.92M SEK
Revenue
257.35M
EBIT %
-88.79 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
18/2
2026
Annual report '25
20/5
2026
Interim report Q1'26
28/5
2026
General meeting '26
All
Webcasts
Press releases
ShowingAll content types
Inbjudan till presentation av BioArctics rapport för fjärde kvartalet oktober - december 2025, den 18 februari, klockan 9:30
Invitation to presentation of BioArctic's fourth quarter report for October - December 2025 on February 18 at 9.30 a.m. CET
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
